1 From the Section of Neonatology, Department of Pediatrics, Medical College of Georgia, Augusta
The effect of ceftriaxone on bilirubin-albumin binding was measured in vitro using the peroxidase method with human serum albumin and a dialysis rate method with adult and newborn serum. Ceftriaxone competes with bilirubin for binding to human serum albumin; the displacement constant is 1.5 x 104 L/mol. Therapeutic levels of ceftriaxone decrease the reserve albumin concentration in newborn serum by 39%. These results indicate that ceftriaxone may increase the risk of bilirubin encephalopathy in jaundiced premature infants.
Key Words: bilirubin-albumin binding ceftriaxone
Submitted on October 22, 1986
Accepted on February 23, 1987
This article has been cited by other articles:
![]() |
J. S. Bradley, D. L.K. Ching, T. A. Wilson, and L. S. Compogiannis Once-Daily Ceftriaxone to Complete Therapy of Uncomplicated Group B Streptococcal Infection in Neonates A Preliminary Report Clinical Pediatrics, May 1, 1992; 31(5): 274 - 278. [Abstract] [PDF] |
||||
![]() |
S. Phillips and G. Kaplan Drug Therapy in Neonatal Sepsis Journal of Pharmacy Practice, January 1, 1989; 2(1): 28 - 35. [Abstract] [PDF] |
||||